Company profile

Prestige Consumer Healthcare

Named as a key player in 33 of our reports, across 33 regions and countries.

Where they show up

33 reports

Our reports that name Prestige Consumer Healthcare as a key player, by category and place.

  • OTC & Nutraceuticals · 33

Places 33

Prestige Consumer Healthcare's markets

1

Markets where they are a key player. Each opens the market's statistics for every place we cover.

OTC & Nutraceuticals1

Recent reports naming Prestige Consumer Healthcare

Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.

All 33 reports

Companies they compete with most

Named as key players in the same markets as Prestige Consumer Healthcare (number of shared markets).

Abbott Laboratories1 shared market Cipla Inc.1 shared market FDC Limited1 shared market Johnson & Johnson1 shared market
Public data

Free public data on Prestige Consumer Healthcare

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Stock listing
NYSE: PBH
Type
Medicines

Source: SEC EDGAR, Company filings, CIK 1295947. Retrieved 13 Nov 2026.

Topics

The topics of the markets Prestige Consumer Healthcare is in.

All topics

From our blog

Stories on the topics Prestige Consumer Healthcare works in.

All stories

Molecular Point-of-Care Tests: Lab Accuracy, Clinic Speed

TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…

Read

Antimicrobial Resistance: Why Faster Testing Matters

Drug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the…

Read

Needleless Connectors: Small Device, Big Infection Impact

Needleless connectors protect staff from needle injuries, but if not cleaned they can let germs into the…

Read

Search all reports for Prestige Consumer Healthcare All companies